Recent Advances in Anti-Aging Medicine

키워드

참고문헌 (84)

1. "South Korea population and housing census 2018" (2018)[URL]
2. Binstock RH, "Anti-aging medicine and research : a realm of conflict and profound societal implications", J Gerontol A Biol Sci Med Sci, 59, pp.B523~33 (2004)
3. Speakman JR, "Caloric restriction", Mol Aspects Med, 32, pp.159~221 (2011)
4. Masoro EJ, "Overview of caloric restriction and ageing", Mech Ageing Dev, 126, pp.913~922 (2005)
5. McCay CM, "The effect of retarded growth upon the length of life span and upon the ultimate body size : one figure", J Nutr, 10, pp.63~79 (1935)
6. Longo VD, "Fasting : molecular mechanisms and clinical applications", Cell Metab, 19, pp.181~192 (2014)
7. Mattison JA, "Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study", Nature, 489, pp.318~321 (2012)
8. Al-Regaiey KA, "The effects of calorie restriction on aging : a brief review", Eur Rev Med Pharmacol Sci, 20, pp.2468~2473 (2016)
9. Walford RL, "The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans", Proc Natl Acad Sci U S A, 89, pp.11533~11537 (1992)
10. Canto C, "Calorie restriction: is AMPK a key sensor and effector?", Physiology (Bethesda), 26, pp.214~224 (2011)
11. Imai SI, "It takes two to tango : NAD(+)and sirtuins in aging", longevity control, 2016, pp.2, 16017~
12. Mitchell SE, "The effects of graded levels of calorie restriction: II. Impact of short term calorie and protein restriction on circulating hormone levels, glucose homeostasis and oxidative stress in male C57BL", 6 mice, 2015, pp.6, 23213~23237
13. Yang F, "mTOR and autophagy in normal brain aging and caloric restriction ameliorating age-related cognition deficits", Behav Brain Res, 264, pp.82~90 (2014)
14. Saraswat K, "Novel strategies for anti-aging drug discovery", Expert Opin Drug Discov, 12, pp.955~966 (2017)
15. Ingram DK, "Calorie restriction mimetics : can you have your cake and eat it, too", Ageing Res Rev, 20, pp.46~62 (2015)
16. Ruderman N, "AMP kinase and malonyl-CoA : targets for therapy of the metabolic syndrome", Nat Rev Drug Discov, 3, pp.340~351 (2004)
17. Rena G, "Molecular mechanism of action of metformin : old or new insights", Diabetologia, 56, pp.1898~1906 (2013)
18. Bannister CA, "Can people with type 2 diabetes live longer than those without? : a comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls", Diabetes Obes Metab, 16, pp.1165~1173 (2014)
19. UK Prospective Diabetes Study(UKPDS)Group, "Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes(UKPDS 34)", Lancet, 352, pp.854~865 (1998)
20. Wu JW, "Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality : a review of the literature", Expert Opin Drug Saf, 13, pp.1071~1099 (2014)
21. Ng TP, "Long-term metformin usage and cognitive function among older adults with diabetes", J Alzheimers Dis, 41, pp.61~68 (2014)
22. Bartke A, "The somatotropic axis and aging : mechanisms and persistent questions about practical implications", Exp Gerontol, 44, pp.372~374 (2009)
23. Junnila RK, "The GH", IGF-1 axis in ageing and longevity, 2013, pp.9, 366~376
24. Trainer PJ, "Treatment of acromegaly with the growth hormonereceptor antagonist pegvisomant", N Engl J Med, 342, pp.1171~1177 (2000)
25. Caron A, "The roles of mTOR complexes in lipid metabolism", Annu Rev Nutr, 35, pp.321~348 (2015)
26. Josse L, "mTORC1 signalling and eIF4E", 4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells, 2016, pp.473, 4651~4664
27. Johnson SC, "mTOR is a key modulator of ageing and age-related disease", Nature, 493, pp.338~345 (2013)
28. Arriola Apelo SI, "Rapamycin : an InhibiTOR of aging emerges from the soil of Easter Island", J Gerontol A Biol Sci Med Sci, 71, pp.841~849 (2016)
29. Soefje SA, "Common toxicities of mammalian target of rapamycin inhibitors", Target Oncol, 6, pp.125~129 (2011)
30. Satoh A, "Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH", Cell Metab, 18, pp.416~430 (2013)
31. Wood JG, "Sirtuin activators mimic caloric restriction and delay ageing in metazoans", Nature, 430, pp.686~689 (2004)
32. Morselli E, "Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy", Cell Death Dis, 1, pp.e10~ (2010)
33. Chung S, "Regulation of SIRT1 in cellular functions : role of polyphenols", Arch Biochem Biophys, 501, pp.79~90 (2010)
34. Howitz KT, "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan", Nature, 425, pp.191~196 (2003)
35. Baur JA, "Resveratrol improves health and survival of mice on a high-calorie diet", Nature, 444, pp.337~342 (2006)
36. Pearson KJ, "Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span", Cell Metab, 8, pp.157~168 (2008)
37. Yang DL, "Resveratrol inhibits right ventricular hypertrophy induced by monocrotaline in rats", Clin Exp Pharmacol Physiol, 37, pp.150~155 (2010)
38. Wu Z, "Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats", Neurochem Res, 34, pp.1393~1400 (2009)
39. Khan MM, "Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson’s disease", Brain Res, 1328, pp.139~151 (2010)
40. Karuppagounder SS, "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer’s disease", Neurochem Int, 54, pp.111~118 (2009)
41. Witte AV, "Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults", J Neurosci, 34, pp.7862~7870 (2014)
42. Bhatt JK, "Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus", Nutr Res, 32, pp.537~541 (2012)
43. Zouboulis CC, "Hormonal therapy of intrinsic aging", Rejuvenation Res, 15, pp.302~312 (2012)
44. Rossouw JE, "Risks and benefits of estrogen plus progestin in healthy postmenopausal women : principal results from the Women’s Health Initiative randomized controlled trial", JAMA, 288, pp.321~333 (2002)
45. Samaras N, "Off-label use of hormones as an antiaging strategy : a review", Clin Interv Aging, 9, pp.1175~1186 (2014)
46. Samaras N, "A view of geriatrics through hormones : what is the relation between andropause and well-known geriatric syndromes", Maturitas, 74, pp.213~219 (2013)
47. 심무열, "Seasonal Variations and Correlations between Vitamin D and Total Testosterone Levels", Korean Journal of Family Medicine, 38(5), pp.270~275 (2017), 대한가정의학회
48. Sattler FR, "Testosterone and growth hormone improve body composition and muscle performance in older men", J Clin Endocrinol Metab, 94, pp.1991~2001 (2009)
49. Bain J, "Andropause : testosterone replacement therapy for aging men", Can Fam Physician, 47, pp.91~97 (2001)
50. Emmelot-Vonk MH, "Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men : a randomized controlled trial", JAMA, 299, pp.39~52 (2008)
51. Kenny AM, "Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailty", J Am Geriatr Soc, 58, pp.1134~1143 (2010)
52. Noble RL, "The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration", Cancer Res, 37, pp.1929~1933 (1977)
53. Pierorazio PM, "Serum testosterone is associated with aggressive prostate cancer in older men : results from the Baltimore Longitudinal Study of Aging", BJU Int, 105, pp.824~829 (2010)
54. Travis RC, "Serum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and Nutrition", Int J Cancer, 121, pp.1331~1338 (2007)
55. Genazzani AD, "Might DHEA be considered a beneficial replacement therapy in the elderly", Drugs Aging, 24, pp.173~185 (2007)
56. Davis SR, "Clinical review : DHEA replacement for postmenopausal women", J Clin Endocrinol Metab, 96, pp.1642~1653 (2011)
57. Valenti G, "Effect of DHEAS on skeletal muscle over the life span : the InCHIANTI study", J Gerontol A Biol Sci Med Sci, 59, pp.466~472 (2004)
58. Ravaglia G, "Determinants of functional status in healthy Italian nonagenarians and centenarians : a comprehensive functional assessment by the instruments of geriatric practice", J Am Geriatr Soc, 45, pp.1196~1202 (1997)
59. Nawata H, "Aromatase in bone cell : association with osteoporosis in postmenopausal women", J Steroid Biochem Mol Biol, 53, pp.165~174 (1995)
60. Clarke BL, "Predictors of bone mineral density in aging healthy men varies by skeletal site", Calcif Tissue Int, 70, pp.137~145 (2002)
61. Barrett-Connor E, "Endogenous sex hormones and cognitive function in older men", J Clin Endocrinol Metab, 84, pp.3681~3685 (1999)
62. Michael A, "Altered salivary dehydroepiandrosterone levels in major depression in adults", Biol Psychiatry, 48, pp.989~995 (2000)
63. Shufelt C, "DHEA-S levels and cardiovascular disease mortality in postmenopausal women : results from the National Institutes of Health--National Heart, Lung, and Blood Institute(NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation(WISE)", J Clin Endocrinol Metab, 95, pp.4985~4992 (2010)
64. Legrain S, "Dehydroepiandrosterone replacement administration : pharmacokinetic and pharmacodynamic studies in healthy elderly subjects", J Clin Endocrinol Metab, 85, pp.3208~3217 (2000)
65. Traish AM, "Dehydroepiandrosterone(DHEA) : a precursor steroid or an active hormone in human physiology", J Sex Med, 8, pp.2960~2982 (2011)
66. Nair KS, "DHEA in elderly women and DHEA or testosterone in elderly men", N Engl J Med, 355, pp.1647~1659 (2006)
67. Vaiserman AM, "Gut microbiota : a player in aging and a target for anti-aging intervention", Ageing Res Rev, 35, pp.36~45 (2017)
68. Konturek PC, "Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases", J Physiol Pharmacol, 66, pp.483~491 (2015)
69. Biagi E, "Gut microbiota and extreme longevity", Curr Biol, 26, pp.1480~1485 (2016)
70. Rampelli S, "Functional metagenomic profiling of intestinal microbiome in extreme ageing", Aging(Albany NY), 5, pp.902~912 (2013)
71. Perez Martinez G, "Understanding gut microbiota in elderly’s health will enable intervention through probiotics", Benef Microbes, 5, pp.235~246 (2014)
72. Rondanelli M, "Review on microbiota and effectiveness of probiotics use in older", World J Clin Cases, 3, pp.156~162 (2015)
73. Eloe-Fadrosh EA, "Functional dynamics of the gut microbiome in elderly people during probiotic consumption", MBio, 6, pp.e00231~15 (2015)
74. Young VB, "Environmental management in the gut: fecal transplantation to restore the intestinal ecosystem", Infect Dis (Lond), 48, pp.593~595 (2016)
75. Rao K, "Fecal microbiota transplantation for the treatment of Clostridium difficile infection", J Hosp Med, 11, pp.56~61 (2016)
76. Hyun Ho Choi, "Fecal Microbiota Transplantation: Current Applications, Effectiveness, and Future Perspectives", Clinical Endoscopy, 49(3), pp.257~265 (2016), 대한소화기내시경학회
77. Wang TJ, "Vitamin D deficiency and risk of cardiovascular disease", Circulation, 117, pp.503~511 (2008)
78. Balion C, "Vitamin D, cognition, and dementia : a systematic review and meta-analysis", Neurology, 79, pp.1397~1405 (2012)
79. Janssen HC, "Vitamin D deficiency, muscle function, and falls in elderly people", Am J Clin Nutr, 75, pp.611~615 (2002)
80. Douglas AS, "Seasonal variation in coronary heart disease in Scotland", J Epidemiol Community Health, 49, pp.575~582 (1995)
81. Rostand SG, "Ultraviolet light may contribute to geographic and racial blood pressure differences", Hypertension, 30(2 Pt 1), pp.150~156 (1997)
82. 김문희, "The Association between 10-Year Atherosclerotic Cardiovascular Diseases Risk Score Calculated Using 2013 American College of Cardiology", American Heart Association Guidelines and Serum 25-Hydroxyvitamin D Level among Aged 40–79 Years in Korea: The Sixth Korea National Health and Nutrition Examination Surveys, 2018, pp.39(3), 174~179[DOI]
83. Deeb KK, "Vitamin D signalling pathways in cancer : potential for anticancer therapeutics", Nat Rev Cancer, 7, pp.684~700 (2007)
84. Pludowski P, "Vitamin D supplementation guidelines", J Steroid Biochem Mol Biol, 175, pp.125~135 (2018)

관련 논문AI추천